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PRELIMINARY AND SHORT REPORTS
TREATMENT OF HERPES ZOSTER WITH MOCCASIN VENOM
CHARLES C. DENNIE, M.D., DAVID B. MORGAN, M.D. AND FRANcIs P. CooMBs, M.D.
Kansas City, Missouri
Since the reports on the treatment of herpes simplex with moccasin venom by Kelly
(1) and Fisher (2) we felt that this substance might be worth a trial in treating herpes zoster.
Kelly also used intradermal injections of moccasin venom for three cases of herpes zoster,
but he felt that although the subjective symptoms of severe burning and itching during the
stage of vesiculation were alleviated, the course of the disease was unaltered. As we have
been unable to find any further reports in the literature concerning the use of this venom
for herpes zoster we thought that a test with a greater number of eases might be worthwhile.
Both diseases are considered by many authors to be due to virus origins and Goeckerman
and Wilhelm (3) have observed both infections simultaneously in one individual. These
last mentioned authors are of the belief that the virus is probably carried by the blood
stream.
REPORT OF CASES
Twenty cases have been included in our series. They ranged in age from twenty-two
to eighty-seven years. Two patients in this group were negro and the remainder were
white. Males outnumbered females fourteen to six. At least forty-eight hours from the
onset of the disease had elapsed before any patient was seen or at least tentatively diag-
nosed.
One patient had been suffering from herpes zoster for seven weeks when first seen by us.
Most of the patients gave a history of having had signs and symptoms for three to eight
days. The lesions were so varied that almost all the spinal nerves were involved, as well
as the fifth cranial nerve.
Moccasin venom diluted 1:3000* was given intradermally in all cases. The initial dose
was 0.10 cc. in all instances. This same amount was maintained in six patients and never
exceeded three injections. One man needed only one intradermal injection. The remain-
ing patients received not higher than 0.30 cc. of the venom. Most of this group received
0.15 cc. on the second injection and 0.20 cc. on the third and last one. One patient was given
0.20 cc. on the second injection and 0.30 cc. on the third and fourth injections. The dosage
interval was set at either two or four days, except for the one patient who received third
and fourth injections of 0.30 cc. The last injection was given after an interval of ten days
because his pain, which had nearly subsided, returned. However, the pain was completely
gone two days later.
The formation of firm crusts from the desiccation of vesicles and bullae occurred from
two to seven days following the first injection of moccasin venom. Only two of these cases
required more than five days for the vesicles to shrink and form an adherent crust. All
crusts had fallen from the lesions leaving healthy pink granulation tissue within ten days
following their formation except in two patients. These two exceptions were due to mild
secondary infection and to the depth of the blebs. However, these lesions were all com-
pletely healed within a two week span.
Pain was the chief complaint in eighteen of this group. Two had no such subjective
symptoms. Two patients received essentially no relief from pain by the moccasin venom
or by any other treatment tried thereafter, which included intramuscular injections of
* Snake venom solution (Moccasin) 1:3000 Lederle Laboratories, Inc., New York, New
York.
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Vitamin B-Complex containing large amounts of thiamine hydrochloride (100 mg. per one
cc.), crude liver, posterior gland and whole gland pituitary extracts, cobra venom and peni..
cillin, as well as intravenous injections of sodium iodide and urotropine. The remaining
sixteen were relieved of pain after intervals varying from thirty-six hours (one man) to
twenty days. A second male was completely free of symptoms in two days after one in-
jection. A third male patient was completely free of pain in three days and a fourth man
(right-handed) with vesicles on the right upper arm and shoulder was so relieved in four
days that he asked permission to play tennis the next afternoon. In this group of sixteen
obtaining relief from pain only four required more than ten days. One female patient com-
plained of severe deep itching (a form of pain?) after subsidence of rather marked pain at
the site of the lesions on the scalp, forehead and face, including the right cornea. This
itching lasted for five weeks before disappearing.
Reactions were minimal. Two patients developed firm erythematous rather pruritic
nodes at the sites of the moccasin venom injections. These lesions did not make their
appearance until one or two days after the third and last intradermal injection had been
administered. These nodes disappeared within four days. Although all patients com-
plained of momentary moderate pain and burning at the site of the injection on the fore-
arm, only three had erythema lasting more than an hour and none over forty-eight hours.
One negro male developed generalized urticaria one week after his third and last injection
of moccasin venom, but it was only of a few hours duration. Since he had had several at-
tacks of "strawberry rash" previously, it could very likely have been due to some food or
other etiological agent.
COMMENT
We do not know the mechanism of action of moccasin venom against the virus of herpes
zoster. In treating three cases of pemphigus with moccasin venom, Peck (4) expressed
the belief that this disease is also caused by a dermatropic virus. He felt that the moccasin
venom produced a barrier in the capillaries of the skin which the virus in the circulation
could not break through to cause the clinical manifestations. We believe that Peck's
hypothesis is probably correct and that such viruses are rather similar. It is also possible
that the venom may destroy these viruses while they are still present in the circulation.
Since we have begun using moccasin venom for herpes zoster, we feel that it is the single
best method of treatment that we have yet tried. However, we feel that no better than
the average results from other commonly accepted forms of therapy will be obtained from
the use of moccasin venom if treatment is not begun at least five days after the appear-
ance of the herpes zoster. In many instances, this venom will not be effective if the disease
has been present more than forty-eight hours.
Age is not too important a factor as determined from our series, although we feel that in
general the best results will be obtained in persons under sixty years of age. Males defi-
nitely seemed to be more responsive to the effects of moccasin venom, as the two patients
who failed to show any signs of improvement were both females.
Heretofore we have always given a guarded prognosis in herpes zoster of the fifth cranial
nerve with involvement of the cornea. In 1946, one of us saw a twenty year old white f e-
male, who lost the sight of her left eye from such involvement. We had not considered the
use of moccasin venom at that time. However, our two patients with corneal inflammation
in this group of twenty recovered with only slight sequellae. One of these two was an
eighty-seven year old white female with inflammation of both corneas. The redness sub-
sided rapidly after the first injection and no scarring or impairment of vision could ever be
noted clinically after follow-up examinations for five weeks. The second patient with
corneal involvement was a thirty year old white female. The inflammation became quite
intense and two ulcerations were visible with fluorescin in the right eye within a period of
twenty-four hours after our first examination. Moccasin venom was then given and the
redness showed definite diminution within forty-eight hours. The ulcers were completely
healed twenty-four hours later and the resultant scars were only pin-point in size. For-
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tunately they were not located over the pupil so that her vision was not impaired. Two
other patients had involvement of the fifth nerve adjacent to the eye, although the corneas
were not affected. Because we wished to prevent such an oecurrence, both patients re-
ceived moccasin venom as soon as possible after our first examination. Probable cornea!
involvement was prevented and no new lesions appeared on the surrounding skin after the
first injection of the venom. One patient, a male physician, was completely well within
forty-eight hours.
Local treatment consisted of calamine lotion, to which in some instances was added bi-
chloride of mercury and liquor carbonis detergens. We do not feel that this lotion had any
appreciable part in the healing of the lesions.
CONCLUSIONS
Although we do not claim that moccasin venom is a specific remedy for herpes zoster,
we do feel that it has given the best results of any single drug that we have so far encoun-
tered in the treatment of this condition. Two of our patients received no relief from the
severe pain accompanying this disease, although the drying and healing of the vesicles and
bullae was probably shortened by a few days from the average healing time.
Four patients had dramatic results in that the lesions were completely well within a
period of four days. This included elimination of pain, present in all instances although
not of a severe nature.
We feel that moccasin venom is of especial value in treatment of those patients with
corneal involvement, or where fifth nerve inflammation is likely to spread to that area.
SUMMARY
1. Eighteen of twenty cases of herpes zoster showed some improvement with intradermal
injections of moccasin venom.
2. Four patients recovered dramatically, and none of them required more than four days
for complete cure and relief of pain.
3. Cornea! involvement is rapidly checked, so that scarring is minimal if ulceration has
already occurred.
4. Reactions from moccasin venom are usually local and are not severe enough to be a
contraindication in any patient with herpes zoster.
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